PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells
Fabiola Cervantes-Gomez(The University of Texas MD Anderson Cancer Center), Varsha Gandhi(The University of Texas MD Anderson Cancer Center)
Cited by 20
Related Papers
Ibrutinib and Venetoclax for First-Line Treatment of CLL
|New England Journal of Medicine|2019|502
Mechanisms of cytotoxicity to Pim kinase inhibitor, SGI-1776, in acute myeloid leukemia
|Blood|2011|161
AT-101 induces apoptosis in CLL B cells and overcomes stromal cell–mediated Mcl-1 induction and drug resistance
|Blood|2008|147
B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia
|Molecular Cancer Research|2017|50
Targeting MET kinase with the small-molecule inhibitor amuvatinib induces cytotoxicity in primary myeloma cells and cell lines
|Journal of Hematology & Oncology|2013|22